Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males C Borrás, J Sastre, D García-Sala, A Lloret, FV Pallardó, J Viña Free radical biology and medicine 34 (5), 546-552, 2003 | 820 | 2003 |
Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-β peptide J Vina, A Lloret Journal of Alzheimer’s disease 20 (s2), S527-S533, 2010 | 574 | 2010 |
Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study CM Gedik, A Collins, J Dubois, P Duez, L Kouegnigan, JF Rees, S Loft, ... Faseb Journal 19 (1), 82-84, 2005 | 515 | 2005 |
Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view G Cenini, A Lloret, R Cascella Oxidative medicine and cellular longevity 2019 (1), 2105607, 2019 | 453 | 2019 |
Oxidative stress in asphyxiated term infants resuscitated with 100% oxygen M Vento, M Asensi, J Sastre, A Lloret, F García-Sala, J Viña The Journal of pediatrics 142 (3), 240-246, 2003 | 407 | 2003 |
Free radicals in exhaustive physical exercise: mechanism of production, and protection by antioxidants J VinÑa, MC Gomez‐Cabrera, A Lloret, R Marquez, JB Minana, ... IUBMB life 50 (4‐5), 271-277, 2000 | 388 | 2000 |
Aβ and tau toxicities in Alzheimer’s are linked via oxidative stress-induced p38 activation: Protective role of vitamin E E Giraldo, A Lloret, T Fuchsberger, J Viña Redox biology 2, 873-877, 2014 | 303 | 2014 |
Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental A Lloret, MC Badia, NJ Mora, FV Pallardó, MD Alonso, J Vina Journal of Alzheimer’s Disease 17 (1), 143-149, 2009 | 270 | 2009 |
[23] Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage M Asensi, J Sastre, FV Pallardo, A Lloret, M Lehner, ... Methods in enzymology 299, 267-276, 1999 | 259 | 1999 |
Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPARγ expression in cultured astrocytes SL Valles, P Dolz-Gaiton, J Gambini, C Borras, A LLoret, FV Pallardo, ... Brain research 1312, 138-144, 2010 | 226 | 2010 |
Mitochondria play a central role in apoptosis induced by α-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling T Weber, H Dalen, L Andera, A Nègre-Salvayre, N Augé, M Sticha, ... Biochemistry 42 (14), 4277-4291, 2003 | 208 | 2003 |
Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress J Viña, A Lloret, R Ortı, D Alonso Molecular aspects of medicine 25 (1-2), 117-123, 2004 | 197 | 2004 |
The effectiveness of vitamin E treatment in Alzheimer’s disease A Lloret, D Esteve, P Monllor, A Cervera-Ferri, A Lloret International journal of molecular sciences 20 (4), 879, 2019 | 172 | 2019 |
Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳ s disease A Lloret, T Fuchsberger, E Giraldo, J Viña Free Radical Biology and Medicine 83, 186-191, 2015 | 167 | 2015 |
Mitochondrial oxidative stress and CD95 ligand: a dual mechanism for hepatocyte apoptosis in chronic alcoholism JB Miñana, L Gómez-Cambronero, A Lloret, FV Pallardó, J Del Olmo, ... Hepatology 35 (5), 1205-1214, 2002 | 163 | 2002 |
Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease A Lloret, MC Badia, E Giraldo, G Ermak, MD Alonso, FV Pallardó, ... Journal of Alzheimer's Disease 27 (4), 701-709, 2011 | 158 | 2011 |
When does Alzheimer′ s disease really start? The role of biomarkers A Lloret, D Esteve, MA Lloret, A Cervera-Ferri, B Lopez, M Nepomuceno, ... International journal of molecular sciences 20 (22), 5536, 2019 | 133 | 2019 |
Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome FV Pallardó, A Lloret, M Lebel, M d’Ischia, VC Cogger, DG Le Couteur, ... Biogerontology 11, 401-419, 2010 | 133 | 2010 |
Multiple evidence for an early age pro-oxidant state in Down Syndrome patients FV Pallardó, P Degan, M d’Ischia, FJ Kelly, A Zatterale, R Calzone, ... Biogerontology 7, 211-220, 2006 | 104 | 2006 |
Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients F Di Domenico, G Pupo, E Giraldo, MC Badìa, P Monllor, A Lloret, ... Free Radical Biology and Medicine 91, 1-9, 2016 | 103 | 2016 |